<DOC>
	<DOCNO>NCT01831466</DOCNO>
	<brief_summary>The study beng do test tofacitinib ointment safe effective people plaque psoriasis . Two dose strength tofacitinib ointment ( 20 mg/g 10 mg/g ) apply twice daily test . The safety effectiveness tofacitinib ointment use 12 week compare safety effectiveness placebo ointment ( vehicle ) use 12 week .</brief_summary>
	<brief_title>Tofacitinib Ointment For Chronic Plaque Psoriasis</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Tofacitinib</mesh_term>
	<criteria>Have mild , moderate severe plaque psoriasis ( psoriasis vulgaris ) least 6 month prior Baseline At Baseline , plaque psoriasis cover 2 % 20 % total body surface area ( BSA ) trunk limb ( exclude palm , sol , nail ) If receive certain treatment , treatment minimum period time ( washout ) Currently nonplaque form psoriasis druginduced psoriasis Require treatment stop medication ( ) prohibit study Have certain laboratory abnormality Baseline Current history certain infection Females pregnant , breastfeeding , childbearing potential use highly effective contraception</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>plaque psoriasis</keyword>
	<keyword>vulgaris</keyword>
	<keyword>topical treatment</keyword>
	<keyword>skin disease</keyword>
	<keyword>papulosquamous</keyword>
	<keyword>Tofacitinib</keyword>
	<keyword>CP-690550</keyword>
	<keyword>Xeljanz</keyword>
	<keyword>psoriasis</keyword>
	<keyword>moderate</keyword>
	<keyword>severe</keyword>
	<keyword>itch</keyword>
	<keyword>nail psoriasis</keyword>
</DOC>